Safflower oil
CAS 8001-23-8
Safflower oil (CAS 8001-23-8) is a pharmaceutical compound with 0 bioactivity targets and 432 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Safflower oil is linked through DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| SAFFLOWER OIL | 9515 | SU | MTHSPL |
| Safflower Oil | 9515 | SU | MTHSPL |
| safflower oil | 9515 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Safflower oil used for in pharmaceutical contexts?
Safflower oil (CAS 8001-23-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Safflower oil?
Safflower oil has 432 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Activated partial thromboplastin time prolonged, Anaemia, Analgesic therapy, Antacid therapy, Anticoagulant therapy. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Safflower oil also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Carthamus Tinctorius Seed Oil with EU status "permitted".
What clinical phase is Safflower oil in?
No phase 1-4 clinical development badge is rendered for Safflower oil because the matched compound identifier rows do not contain a max-phase value.